These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 20458435)

  • 21. Alterations in the expression of PDCD4 in ductal carcinoma of the breast.
    Wen YH; Shi X; Chiriboga L; Matsahashi S; Yee H; Afonja O
    Oncol Rep; 2007 Dec; 18(6):1387-93. PubMed ID: 17982621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where do we place PankoMab in the reagents used to study the MUC1 superfamily?
    Li J; Sullivan CA; Harris L
    Onkologie; 2009 May; 32(5):235-7. PubMed ID: 19420968
    [No Abstract]   [Full Text] [Related]  

  • 23. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X; Wei L; Tang C; Slack R; Montgomery E; Lippman M
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor.
    Suzuki T; Miki Y; Moriya T; Shimada N; Ishida T; Hirakawa H; Ohuchi N; Sasano H
    Cancer Res; 2004 Jul; 64(13):4670-6. PubMed ID: 15231680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
    Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
    Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.
    Yang S; Du J; Wang Z; Yan J; Yuan W; Zhang J; Zhu T
    Int J Biochem Cell Biol; 2009 Apr; 41(4):853-61. PubMed ID: 18805502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression analysis of periostin in human breast cancer.
    Zhang Y; Zhang G; Li J; Tao Q; Tang W
    J Surg Res; 2010 May; 160(1):102-6. PubMed ID: 19524268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma.
    Denkert C; Weichert W; Winzer KJ; Müller BM; Noske A; Niesporek S; Kristiansen G; Guski H; Dietel M; Hauptmann S
    Clin Cancer Res; 2004 Aug; 10(16):5580-6. PubMed ID: 15328200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
    Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
    Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
    Lawrence JA; Merino MJ; Simpson JF; Manrow RE; Page DL; Steeg PS
    Cancer Epidemiol Biomarkers Prev; 1998 Jan; 7(1):29-35. PubMed ID: 9456240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma.
    Scintu M; Vitale R; Prencipe M; Gallo AP; Bonghi L; Valori VM; Maiello E; Rinaldi M; Signori E; Rabitti C; Carella M; Dallapiccola B; Altomare V; Fazio VM; Parrella P
    Cancer Lett; 2007 Sep; 254(2):298-307. PubMed ID: 17498870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein Z/protein Z-dependent protease inhibitor system in human non-small-cell lung cancer tissue.
    Sierko E; Wojtukiewicz MZ; Zimnoch L; Ostrowska-Cichocka K; Tokajuk P; Ramlau R; Kisiel W
    Thromb Res; 2012 Apr; 129(4):e92-6. PubMed ID: 21975032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
    Kim TH; Huh JH; Lee S; Kang H; Kim GI; An HJ
    Histopathology; 2008 Jul; 53(1):48-55. PubMed ID: 18479414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.
    Namba R; Maglione JE; Young LJ; Borowsky AD; Cardiff RD; MacLeod CL; Gregg JP
    Mol Cancer Res; 2004 Aug; 2(8):453-63. PubMed ID: 15328372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-data analysis as a strategy to evaluate individual and common features of proteomic changes in breast cancer.
    Zakharchenko O; Greenwood C; Lewandowska A; Hellman U; Alldridge L; Souchelnytskyi S
    Cancer Genomics Proteomics; 2011; 8(1):1-14. PubMed ID: 21289332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer.
    Himmelfarb M; Klopocki E; Grube S; Staub E; Klaman I; Hinzmann B; Kristiansen G; Rosenthal A; Dürst M; Dahl E
    Cancer Lett; 2004 Feb; 204(1):69-77. PubMed ID: 14744536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative analysis of three-dimensional human mammary epithelial tissue architecture reveals a role for tenascin-C in regulating c-met function.
    Taraseviciute A; Vincent BT; Schedin P; Jones PL
    Am J Pathol; 2010 Feb; 176(2):827-38. PubMed ID: 20042668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentration of protein Z and protein Z-dependent protease inhibitor in patients with haemophilia A.
    Bolkun L; Galar M; Piszcz J; Lemancewicz D; Kloczko J
    Thromb Res; 2013 Mar; 131(3):e110-3. PubMed ID: 23269381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.